National Registry of Adult Heart Failure Patients With Complex Congenital Heart Disease: Systemic Right Ventricle and Single Ventricle Treated With Sacubitril/Valsartan

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Complex Congenital Heart Disease

Interventions

DRUG

Sacubitril / Valsartan Oral Tablet [Entresto]

efficacy and tolerability of Sacubitril/Valsartan in the treatment of chronic heart failure on complex congenital cardiopathy

Trial Locations (1)

RECRUITING

Chu Grenoble Alpes, La Tronche

All Listed Sponsors

lead

University Hospital, Grenoble

OTHER